The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and ...
After initially rejecting Moderna’s application for review, the FDA will now consider the company’s mRNA flu shot ...
The Food and Drug Administration rejected Moderna's new flu shot. This raises questions about what it means for the future of vaccine development.
We get the latest from the Munich Security Conference, where U.S. Secretary of State Marco Rubio delivered a speech before European leaders. We also look at the reasons behind why the FDA rejected ...